DNA from Vaccinia virus strain Modified Vaccinia Virus Ankara (MVA) [ATCC® VR-1508™] (ATCC® VR-1508D)

Organism: Vaccinia virus  / 

Product Format frozen
100 µL per vial
Storage Conditions -70°C or colder
Applications
It is suitable for use in PCR and other molecular virology applications.
Comments
Vaccinia virus DNA, in total DNA isolated from BHK-21 cells infected with Vaccinia Virus, strain Modified Vaccinia Virus Ankara (MVA). This product was prepared using methods known to inactivate viruses. It is suitable for use in PCR and other molecular virology applications.

Contact Technical Service if lot-specific concentration information is needed prior to purchase
Biosafety Level 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Quality Control Specifications
  1. Store at -20°C or colder. -70°C or vapor-phase liquid nitrogen (-196°C) is preferred for long-term storage (more than one month).
  2. Integrity is inferred from observation of high molecular weight cellular DNA following electrophoresis of 20 µL of product on a 0.8% agarose gel, visualized by Ethidium bromide staining.
  3. Functional activity is demonstrated by PCR amplification of a 500-3,000 bp amplicon using virus-specific primers.
  4. Identity is confirmed by sequencing of approximately 300 bp to 1Kb of the PCR amplicon.